Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.
about
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueCeliac disease, inflammation and oxidative damage: a nutrigenetic approachCross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac diseaseGliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturationGliadin fragments and a specific gliadin 33-mer peptide close KATP channels and induce insulin secretion in INS-1E cells and rat islets of langerhansParallels between pathogens and gluten peptides in celiac sprueSeroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-The immune recognition of gluten in coeliac disease.Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.Anti-gluten immune response following Toxoplasma gondii infection in miceGliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challengePepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation.Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.Epithelial transport of immunogenic and toxic gliadin peptides in vitro.Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.Food-induced immune responses as origin of bowel disease?Possible drug targets for celiac disease.Understanding the molecular basis of celiac disease: what genetic studies reveal.Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.Antigen presentation in celiac disease.Endocytosis in enterocytes.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases.The intestinal barrier: a fundamental role in health and disease.Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.Association between celiac sprue and cryopyrin associated autoinflammatory disorders: a case report.In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain.Oral proteases: a new approach to managing coeliac disease.Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response.Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population.A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence.Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.Interferon-γ mediates antigen trafficking to MHC class II-positive late endosomes of enterocytesProlamins of maize and wheat differentially affect intestinal cells both in biopsies of celiac patients and CACO-2 cell line
P2860
Q24538575-5C4D61A9-766A-41DD-BED0-03BE5A41FCB2Q24627269-0DAE5740-ECD3-4166-93D7-75D45B40FD4FQ24680243-476182FC-D056-452E-BEE3-210B809EBEDDQ27321328-5B44C186-C6FE-4498-8BF4-B7ACBE991B33Q28533922-292A6248-E270-4352-82F6-87172C039931Q33329537-B902C083-BBE6-4F84-B853-40E7559075E7Q33823449-01F3C0A0-5A11-44CA-8934-FE96F03F0587Q34009143-F312311F-70E9-4BA6-96E6-3A2D20B0E0BDQ34068869-B2F2AEFD-A9D5-49EA-AB1B-A114D2E3FD36Q34423420-2F6A8C63-B0EA-46E1-A2CA-DF122C4E978CQ34470900-C0C2B615-ABEC-4D82-8091-13EE62B36FA0Q34500800-D3734EC5-E67F-4500-9AEE-0AD8C558872BQ34566764-2164DCF0-8D97-4C3E-96AE-919B38BF6039Q34640687-45D67FEA-6476-40CE-8DDF-05188F44B9CDQ34712071-D101ABC9-1A01-4EF2-AB48-4FC5C69AA075Q35212830-EF2F51D3-7DD5-4584-909B-2419157F8AFEQ35442538-EF7CE91A-EEE7-4F2B-AF01-90CAF7610FD2Q35655989-AE6FCFBC-F577-4CA6-8C8F-768E6D9507D4Q35869122-E78FF23D-44FF-47DA-B8F3-BA1A3EAA3864Q36198017-70EE8229-4CD1-4287-8392-30FB81E69334Q36539486-9BEDF374-4047-4AFB-A31D-230CAEDAF116Q36793674-AD3A35B8-5A43-4AF7-AB5B-11B1BFE549D4Q37041073-573015DD-04C8-44C3-83C3-D59126297D6DQ37430981-2465DD88-22A1-4843-86B0-CC32361B50E0Q38780999-EA51DCA8-4310-464C-968A-28A764D285A2Q38810502-D68D1907-3F42-4BED-922B-7C1E815E0B32Q39025229-DD00077C-9F12-4F99-A385-018E26F65CFEQ39398254-72DE8884-1795-482D-8B12-FB5589456EEBQ40246836-34973DEF-C122-4A77-8D9F-C7EA617D75B1Q40448119-38848A76-0499-478E-8B14-0CC7F03B1EBDQ40526966-0E05D11C-3212-4631-AE7B-5D1A8F9C17B9Q42061479-C9AEC82B-579D-4F21-95D4-DE6DB74610ACQ42441197-3C5A39B5-6CC4-403C-A90E-6D8EF3D50A1FQ42482567-262B9494-3AA0-4C02-9391-4DE915BF8E36Q46487852-B809FC57-5B35-4236-82E6-8AABAE4FBF35Q47163293-EF741A7E-D04B-4AED-9F11-98B02E55A7B6Q47842891-8F866D45-2825-42ED-B59C-EC08A6C8ECFCQ54514144-2EF4F3DB-BB33-4DE6-B14F-1EB3A5B3F219Q57916154-54278631-13FC-42F8-9F44-8B25AAF5149CQ58327078-B83CF9F5-4F5D-4988-BC18-5DF7F6A09B5B
P2860
Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alterations of the intestinal ...... in peptides in celiac disease.
@ast
Alterations of the intestinal ...... in peptides in celiac disease.
@en
type
label
Alterations of the intestinal ...... in peptides in celiac disease.
@ast
Alterations of the intestinal ...... in peptides in celiac disease.
@en
prefLabel
Alterations of the intestinal ...... in peptides in celiac disease.
@ast
Alterations of the intestinal ...... in peptides in celiac disease.
@en
P2093
P50
P1433
P1476
Alterations of the intestinal ...... in peptides in celiac disease.
@en
P2093
Celine Candalh
Christophe Cellier
Christophe Dugave
Martine Heyman
P304
P356
10.1016/S0016-5085(03)01049-7
P407
P577
2003-09-01T00:00:00Z